New figures show melanoma most common cancer in young Queenslanders
8 January 2016
Around 110 melanomas are diagnosed in males aged under 35 each year, followed by 80 cases of testicular cancer, while around 140 new cases of melanoma are diagnosed in Queensland females under 35. Thyroid cancer is the second most common cancer in this group affecting more than 60 women each year.
Commenting on the statistics MIA’s Research Director Professor Graham Mann highlighted that sun and solarium exposure are the most common causes of melanoma in younger people.
“We must remember that melanoma rates are influenced by UV radiation exposure that has happened many years earlier, especially in the formative years. The variances we are seeing may be because of the way men and women have used sunbaking and solariums differently.
“Many teenage girls and young women deliberately sunbake and may not cover up with a hat or protective clothing, so maybe this is having an impact. Or possibly male-female biology may be a factor. But man or woman, pursuing that summer glow is a gamble and ultimately can cost you a lot more than it’s worth,” Professor Mann said.
The latest Queensland figures are based on 2012 data prior to the banning of sun beds.
“Fortunately commercial solariums have been banned since about 2014. This was partly because we’ve learned that, among people who used solariums, most of their melanomas before the age of 30 were due to sunbed use. Women were about twice as likely to use sunbeds as men were, and maybe that is also contributing to the different rates we are seeing,” Professor Mann added.
Queensland has the highest rates of skin cancer in the world. Around 3,000 melanoma and 133,000 non-melanoma skin cancers are diagnosed across the state each year.
You can read more on this story here.
SAVE THE DATE:
We want to thank every member of Team Melanoma and everyone who donated to them. With your help, we are moving closer to our goal of zero deaths from melanoma!
Lauren O'Brien tells us why she's running for a cause close to her heart
MIA could not do what we do without the incredible support and effort of our community fundraisers. We’d like to highlight some of the wonderful events organised by our community in
An international study, led by researchers from Melanoma Institute Australia, QIMR Berghofer Medical Research Institute and The University of Sydney as part of the Australian Melanoma Genome Project, has discovered that a drug traditionally used to treat a
Researchers from Melanoma Institute Australia took centre stage at the American Society of Clinical Oncology Annual Meeting in Chicago. Results presented by MIA’s contingent have the potential to create better patient outcomes and change the way advanced melanoma
Today is International Clinical Trials Day – a day to recognise and thank the amazing people who conduct, organise, and coordinate clinical trials.
“I’m the age Emma was when she passed away. It almost feels
As always, part of the PBAC process invites clinicians, patients and other stakeholders in the cancer community to make submissions
As always, part of the PBAC process invites clinicians, patients and other stakeholders in the cancer community to make submissions in support of the PBS listing.
MIA had four winners in the 2017 Premiers Awards. Find out how winning has influenced their work over the past year.
Cancer Council awards Melanoma Institute Australia researchers funding for ground-breaking cancer research projects
Almost $9 million of new funding was awarded to 13 ground-breaking cancer research projects at the 2019 Cancer Council NSW Research Awards.
Georgina V. Long is co-medical director of Melanoma Institute Australia and Chair of Melanoma Medical Oncology and Translational Research. She is the first woman president of the Society for Melanoma Research.
Quintessential Aussie girl and media personality Sophie Monk has been announced as a National Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign, Melanoma March.
Australian researchers have for the first time identified specific cells and receptors in the immune system which predict how a patient will respond to treatment with immunotherapies, potentially paving the way for the development of personalised therapy for all cancer patients.
Melanoma March is thrilled to introduce Ricky as our official Principal Partner for 2019!
World record holder, Olympian and Australian swimming champion Cate Campbell has been announced as National Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign, Melanoma March.
MIA's expertise was essential to a recent Nature publication spearheaded by Perth’s Telethon Kids Institute and The University of Melbourne.
MIA is delighted to be hosting the MD Anderson pathologist on his first ever trip to Australia.
Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for dabrafenib and trametinib.